[18F]-T807 PET/CT Imaging of Tau Pathology in Young Onset Focal Dementia
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease; Dementia; Primary progressive aphasia
- Focus Diagnostic use
- 10 Jun 2017 Biomarkers information updated
- 29 Mar 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2017.
- 11 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.